Merrimack Pharmaceuticals, Inc.
ANTI-TNFR2 ANTIBODIES AND USES THEREOF
Last updated:
Abstract:
Disclosed herein are anti-TNFR2 antibodies, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer and autoimmune diseases.
Status:
Application
Type:
Utility
Filling date:
28 Feb 2020
Issue date:
8 Sep 2022